InvestorsHub Logo

2dollarbill

08/11/18 10:16 AM

#16878 RE: Type0neg #16873

TypeOneg great Thera DD you found!!!

great DD and write up

1234zxcv

08/11/18 2:16 PM

#16910 RE: Type0neg #16873

Nice post,LCLP will exit subpenny in hurry.. multi patents..approved..pending..in preparation LCLP/CEO serves as CFO, Treasurer, Secretary, VP for Therakine since 2015...
http://therakine.com/

TheraKine, Inc.
United States of America TheraKine, Inc.
TheraKine Limited is a privately held drug delivery company. The Company has developed novel drug delivery technology for biologics and small molecules that address drug delivery challenges in multiple therapeutic areas. The Company has multiple patents approved, pending, and in preparation.

https://www.cmocro.com/company/TheraKine%2C+Inc./index.html

cjstocksup

08/11/18 5:36 PM

#16937 RE: Type0neg #16873

LCLP SOME DD on Therakine

Therakine have a legit, sustaining delivery method here that could or is already bringing in millions of revenue. Especially if they tie it to cannabis and could already have the products developed for the medical cannabis industry. I think they're keeping that hush at the moment as their website is down.

Remember at only a 50mm marketcap puts this at $.04 but I think we're headed higher.

These are some of the companies our IR company represents.
MariMed Inc $511 Million
Marijuana Company of America $66 Million
SQL Technologies Corp $160 Million
Kaya Holdings $20 Million


Mr. Yakatan: In simple forms, we
figured out a way to take an existing
drug and extend its life, whether it is
hydrophobic or hydrophilic. We can
then place, for example, a six months
supply of the drug directly into the
body and have it released exactly
when it needs to be. What is unique is
that we use physics, instead of modifying
the drug chemically: we mechanically
form biopolymers or biopolymer
derivatives using only already
approved additives. Then we
modify those carefully under controlled
conditions. Then we create a
number of cycles of pressing and
kneading that transform the mixture
of ingredients into a polymer elastic
body of high stability.


Here is info about Therakine licencing their delivery method for Naltrexone to BicxCorp (52 week high of .$28) with an estimsted demand of $185 million in 2016.

https://ir.biocorrx.com/press-releases/detail/59/biocorrx-announces-license-agreement-with-therakine-ltd-to

Another licensing deal:
https://finance.yahoo.com/news/therakine-cell-care-therapeutics-engage-125051964.html